SCHEMBL19654199

SCHEMBL19654199

CNC(=O)c1ccccc1Nc1nc(Nc2cc(C)c(OC)c(OC)c2)ncc1C

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ULK1 O75385 2/20 0.68
▸ PTK2 Q05397 14/20 0.68
▸ FGFR1 P11362 2/20 0.68
▸ FGFR3 P22607 2/20 0.68
▸ FGFR2 P21802 1/20 0.68
▸ FGFR4 P22455 1/20 0.68
▸ PKMYT1 Q99640 2/20 0.60
▸ PRKAA1 Q13131 2/20 0.58
▸ PRKAA2 P54646 1/20 0.58
▸ ULK2 Q8IYT8 1/20 0.58
▸ JAK2 O60674 2/20 0.56
▸ JAK3 P52333 2/20 0.56
▸ MAPK9 P45984 2/20 0.56
▸ CDC7 O00311 1/20 0.56
▸ PLK4 O00444 1/20 0.56
▸ CHEK1 O14757 1/20 0.56
▸ DCLK1 O15075 1/20 0.56
▸ CHUK O15111 1/20 0.56
▸ PDPK1 O15530 1/20 0.56
▸ DAPK3 O43293 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23754823 0.96 PTK2 (0.73) ULK1PTK2FGFR1FGFR3FGFR2
SCHEMBL19654194 0.92 ULK1 (0.65) ULK1PTK2FGFR1FGFR3FGFR2
SCHEMBL19654219 0.88 ULK1 (0.63) ULK1PTK2FGFR1FGFR3FGFR2
SCHEMBL19654234 0.87 ULK1 (0.62) ULK1PTK2FGFR1FGFR3FGFR2
SCHEMBL19654228 0.87 ULK1 (0.91) ULK1PTK2FGFR1FGFR3FGFR2
SCHEMBL17547467 0.86 PTK2 (0.75) ULK1PTK2FGFR1FGFR3FGFR2
SCHEMBL23754871 0.86 PTK2 (0.72) ULK1PTK2FGFR1FGFR3FGFR2
SCHEMBL17544689 0.86 PTK2 (0.72) ULK1PTK2FGFR1FGFR3FGFR2
SCHEMBL30086170 0.86 PTK2 (0.72) ULK1PTK2FGFR1FGFR3FGFR2
SCHEMBL23754829 0.86 PTK2 (0.72) ULK1PTK2FGFR1FGFR3FGFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170342088-A1 NOVEL ULK1 INHIBITORS AND METHODS USING SAME SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 2017-11-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170342088-A1 NOVEL ULK1 INHIBITORS AND METHODS USING SAME ULK1, ULK2, ULK3 ULK1 1/4885PTK2 884/4885FGFR1 1715/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback